TropIQ awarded large research grant to uncover new mosquito repellents. By Angelika Sturm21/09/202123/09/2021 Categories: News Together with researchers from the University of Washington, TropIQ was awarded 1.3 million USD from the Bill & Melinda Gates Foundation to find new mosquito repellents and…
MalDA prioritises malaria drug targets with TropIQ’s input By Angelika Sturm17/09/2021 Categories: News The Malaria Drug Accelerator (MalDA), of which TropIQ is part of, has put together a prioritisation of molecular targets against the malaria parasite Plasmodium falciparum. This publication further…
Our team aids the discovery of a new anti-malarial scaffold. By Angelika Sturm31/08/202131/08/2021 Categories: News Due to the continuing rise of resistances against commonly used medication, new anit-malarials are needed to combat the disease. This publication suggests Quinazolinone-2-carboxamide derivatives as a novel malaria…
Review of MalDA’s scientific achievements just released By Angelika Sturm10/07/202117/09/2021 Categories: News TropQI has been a part of The Malaria Drug Accelerator (MalDA) since 2018. This consortium consists of 17 research laboratories funded by the Bill and Melinda Gates foundation…
Our liver stage platform supports life cycle profiling for new anti-malarial. By Angelika Sturm15/06/202131/08/2021 Categories: News In the battle against malaria new drugs are needed. This publication identified 1-(pyridine-4-yl)pyrrolidine-2-one derivates as a novel, dual stage active (asexual blood stages and liver stage), anti-malaria. read…
TropIQ assists in life cycle profiling of genetically modified chimeric Plasmodium parasite. By Angelika Sturm21/12/202031/08/2021 Categories: News To broaden the protective spectrum of a potential whole parasite vaccine against malaria, a chimeric P. falciparum parasite expressing P. falciparum and P. vivax circumsporozoite protein (csp) was…
TropIQ Digitalises Its Discovery Platform with CDD Vault By Koen Dechering13/10/202014/10/2020 Categories: News CDD Vault will enable TropIQ Health Sciences to share research results with partners in real time Nijmegen and San Francisco — October 8, 2020 TropIQ Health Sciences, a…
TropIQ contributes to research on malaria vaccine By Angelika Sturm11/01/202020/02/2020 Categories: News Production of the primary vaccine candidate Plasmodium falciparum circumsporozoite protein (PfCSP) has proven difficult. This publication for the first time presents a method to produce a soluble, full-length…
Dr. Sheshachalam is joining TropIQ By Angelika Sturm01/10/201904/10/2019 Categories: News Dr. Sheshachalam has joined the team as a Scientist. He is an experienced cell biologist with a broad expertise in immunology, molecular biology and drug discovery. He obtained…
TropIQ CEO Koen Dechering gives radio interview on the new malaria drug candidate By Angelika Sturm19/09/201919/09/2019 Categories: News Dutch national radio (BNR) has conducted an interview with TropIQ’s CEO Koen Dechering on the recently published novel malaria drug candidate (see publication here). Listen to the interview…
TropIQ-led collaboration develops novel malaria candidate drug By Angelika Sturm19/09/201922/09/2019 Categories: News A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch…
TropIQ gains new Assistant Scientist By Angelika Sturm14/09/201904/10/2019 Categories: News Mrs. De Bruijn is joining the Team as a Assistant Scientist with a wealth of experience in laboratory techniques in the fields of immunology, cell biology and molecular…
TropIQ gains Business Administrator By Angelika Sturm14/08/201923/08/2019 Categories: News Mrs. Bijsterveld is joining TropIQ as a Business Administrator with a strong background in financial management in various different fields of work. In her previous affiliations she acquired…
TropIQ at the ICM Weekend School By Angelika Sturm12/05/201915/05/2019 Categories: News TropIQ organised a science workshop at the IMC Weekend School. This is a supplementary school on Sundays for children (aged 10-14) from underprivileged neighbourhoods. Through a three-year course,…
New master student at TropIQ By Angelika Sturm01/05/201917/03/2022 Categories: News Ms. Sascha Bezemer is joining the team as our new intern. She is a biology master student with specialisation in health and disease. She is enrolled at Wageningen…
TropIQ’s CSO, Robert Sauerwein knighted By Angelika Sturm26/04/201915/05/2019 Categories: News Robert Sauerwein, CSO of TropIQ, receives a royal decoration for his pioneering work in malaria vaccinology and drug discovery. He receives the distinction of Knight in the Order…
Scientist Dr. Youri van Nuland is joining the team By Angelika Sturm01/03/201925/03/2019 Categories: News Dr. van Nuland is an experienced biochemist with a PhD from Wageningen University in the Netherlands. He is an expert in industrial biotechnology and previously worked on metabolic…
New intern Tom Seijger starting By Angelika Sturm11/02/201925/03/2019 Categories: News Mr. Seijger is an undergraduate student at the Saxion University of Applied Sciences in Enschede. He will be doing an internship contributing to projects involving malaria transmission. He…
Dr. Marnix Vlot is joining TropIQ as a postdoctoral scientist. By Angelika Sturm01/10/201808/10/2018 Categories: News Dr. Vlot has earned his PhD in molecular microbiology at Wageningen University. He specialises in the molecular mechanism of the CRISPR-Cas gene editing system and will apply his…
Annemijn Grol joins the team. By Angelika Sturm24/09/201829/10/2018 Categories: News Ms. Grol is an undergraduate student at the Avans University of Applied Sciences in Breda. She will be doing an internship contributing to our dengue project. She will…
TropIQ on national TV By Angelika Sturm21/07/201808/10/2018 Categories: News As a reaction to TropIQs latest study preventing transmission of tropical diseases, published in PNAS in July this year, the Dutch television program EenVandaag (NPO1) presented an item…
Science Magazine writes about TropIQ’s latest publication. By Angelika Sturm05/07/201826/09/2018 Categories: News The scientific journal Science report on TropIQ’s finding that dog’s flea and tick medication could prevent the spread of vector borne diseases like malaria and Zika. Click here…
Time Magazine reports on TropIQ’s finding. By Angelika Sturm04/07/201826/09/2018 Categories: News Time Magazine has reported on TropIQ’s finding that veterinary drugs have the potential to protect humans from malaria, Zika, and other diseases transmitted by blood feeding insects. Read…
TropIQ publishes description of oral insecticides for vector-borne disease control. By Angelika Sturm03/07/201812/07/2018 Categories: News Our research shows that, given to humans, insect killing veterinarian drugs can greatly reduce
Rianne van der Laak is joining TropIQs team as a Research Technician By Angelika Sturm01/05/201815/05/2018 Categories: News Ms. van der Laak has previously worked in a variety of companies, which allowed her to
Tonnie Huijs is joining TropIQ as an assistant scientist By Angelika Sturm16/04/201815/05/2018 Categories: News Mr. Huijs is an expert in tissue culture and assay development. He gained his experience
TropIQ team contributes to discovery of multiple stage malaria compound By Angelika Sturm10/03/201828/03/2018 Categories: News New research, with TropIQ contribution, on a compound series active against malaria asexual and sexual stages was published today. Read more here.
TropIQ hosts the Dutch Malaria Day By Angelika Sturm16/02/201819/02/2018 Categories: News Once a year malaria research groups in the Netherlands come together to share their newest results, discuss future plans and collaborative efforts. This year this event was organised…
Dr. Sameera Patel is joining TropIQ as the first virologist in the laboratories. By Angelika Sturm21/01/201819/02/2018 Categories: News Dr. Patel is a virologist who has worked at the University in Cambridge and
TropIQ latest manuscript published today. By Angelika Sturm15/12/201712/01/2018 Categories: News TropIQ publishes novel modelling method for predicting the effectiveness of drugs on malaria transmission. The publication “Modelling mosquito infection at natural parasite densities
Deeya Shankari Rajagopal joins the TropIQ team By Angelika Sturm05/09/201720/09/2017 Categories: News Deeya is a master student from the HAN University of Applied Sciences and will be with us for two years.
Annemarie Barink joins TropIQs team By Angelika Sturm22/08/201722/08/2017 Categories: News Annemarie is an HBO student and will stay with us for a six months internship.
TropIQ enters partnership to combat vector-borne diseases By Angelika Sturm13/07/201724/07/2017 Categories: News TropIQ joins forces with Protinhi Therapeutics, Radboud University and the Radboud University Medical Center in a project aimed at the discovery of novel therapeutics for malaria, dengue and…
TropIQ co-authors nature communications publication. By Angelika Sturm11/07/201720/09/2017 Categories: News TropIQ co-authors the publication “A potent series targeting the malarial cGMP-dependent protein
Godelieve Bosman joins the TropIQ team as a laboratory attendant By Angelika Sturm10/05/201722/08/2017 Categories: News
TropIQ team contributes to study on Plasmodium kinase inhibitor By Angelika Sturm26/04/201701/05/2017 Categories: News The publication “Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.” came out today.
TropIQ receives price for Dutch innovative startup By Monique06/12/201614/04/2017 Categories: News TropIQ receives the Unilever Sustainable Innovation Prize for the Dutch innovative startup best contributing to the Sustainable Development Goals as put forward by the United Nations.
TropIQ staff co-authors publication on novel antimalarial compound By Monique04/10/201619/04/2017 Categories: News October 4, 2016. TropIQ staff co-author the study ‘Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling’ published in PloS Medicine today.
TropIQ is awarded with a ‘Pearl of the region’ By Monique15/09/201606/03/2017 Categories: News TropIQ is awarded with a ‘Pearl of the region’ award by The Economic Board. Waarom roept The Economic Board ‘parels van de regio’ in het leven? De Board…
TropIQ staff co-authors paper in Nature By Monique07/09/201606/03/2017 Categories: News Nature publishes the paper ‘Diversity-oriented synthesis yields novel multistage antimalarial inhibitors’ that is co-authored by TropIQ staff. Antimalarial drugs have thus far beenchiefly derived from two sources—natural products…
Malaria Journal publishes our newest paper ” An inter-laboratory comparison of the Standard Membrane Feeding Assay” By Angelika Sturm05/09/201619/04/2017 Categories: News Here the “gold standard” status for transmission blocking activity of antibodies, the standard membrane feeding assay (SMFA), is verified in two different laboratories. Read the article here.
Laura Pelser-Posthumus joins the TropIQ as a laboratory attendant By Angelika Sturm01/06/201619/04/2017 Categories: News
TropIQ moves to different location By Angelika Sturm31/05/201619/04/2017 Categories: News TropIQ has moved to a brand new laboratory at the Noviotech campus in Nijmegen, The Netherlands.
Malaria Journal publishes our contribution to the development of a novel malaria cocktail vaccine. By Angelika Sturm17/05/201619/04/2017 Categories: News Read full article here.
Marie Miglianico joins the TropIQ team as a scientist By Angelika Sturm09/05/201619/04/2017 Categories: News
TropIQ enters consortium By Angelika Sturm25/04/201619/04/2017 Categories: News TropIQ has entered a Netherlands-based consortium that teams up with MMV in world-leading malaria translational research.
TropIQ enters partnership By Angelika Sturm31/01/201619/04/2017 Categories: News TropIQ enters partnership with MMV (Medicines for Malaria Venture) on generation of a pantothenamide clinical candidate.
Rob Henderson joins the TropIQ team as a research technician By Angelika Sturm11/01/201619/04/2017 Categories: News
Scientific Reports publishes our paper By Angelika Sturm21/12/201519/04/2017 Categories: News “A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes” We describe here for the first time a…
TropIQ receives research grant By Angelika Sturm12/11/201519/04/2017 Categories: News TropIQ receives a Grand Challenges and Explorations award from the Bill & Melinda Gates Foundation to develop barcoded insect screens for optimization of artificial diets.
TropIQ co-authors Scientific Report publication By Angelika Sturm10/11/201519/04/2017 Categories: News TropIQ staff co-authors the study ‘A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds’ that was published by Scientific…
TropIQ employees co-author published study By Angelika Sturm07/07/201519/04/2017 Categories: News TropIQ employees co-author the study ‘A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria’ that was published by Science Translational Medicine today.
TropIQ contribute to vaccine cocktail study By Angelika Sturm06/07/201519/04/2017 Categories: News TropIQ contributed to the study ‘Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate—Tackling the Cocktail Challenge’ that was published by Plos One today.
Co-authorship in Nature publication By Angelika Sturm18/06/201519/04/2017 Categories: News Nature publishes the paper ‘A novel multiple-stage antimalarial agent that inhibits protein synthesis’ that is co-authored by TropIQ.
TropIQ employees co-author publication By Angelika Sturm08/06/201519/04/2017 Categories: News TropIQ employees co-author the manuscript ‘Salinomycin and other ionophores as new class of antimalarial drugs with transmission blocking activity’ that appeared in Antimicrobial Agents and Chemotherapy today.
Angelika Sturm joins the TropIQ team as a senior scientist By Angelika Sturm05/06/201519/04/2017 Categories: News
TropIQ co-authors manuscript By Angelika Sturm21/04/201520/04/2017 Categories: News TropIQ employees co-author the manuscript Novel pantothenate derivatives for anti-malarial chemotherapy that appeared in Malaria Journal today.
Maarten Eldering joins the TropIQ team as a scientist By Angelika Sturm27/03/201520/04/2017 Categories: News
Dutch regional television reported on TropIQ’s mission. By Angelika Sturm25/02/201520/04/2017 Categories: News Watch the full video here
TropIQ publishes validation of transmission assay By Angelika Sturm09/02/201502/05/2017 Categories: News In the publication “A combination of new screening assays for prioritization of transmission-blocking antimalarials